CompletedNot Applicable

Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility

Egypt226 participantsStarted 2015-04

Plain-language summary

Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting substance, is a dimeric glycoprotein that belongs to the transforming growth factor-beta family. It is involved in the regression of the Müllerian ducts during male fetal development. In the female, AMH is solely produced by the granulosa cells of preantral and small antral follicles, and regulates ovarian activity and follicular steroidogenesis

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women with diagnosed mullerian anomlies whether clinically or through imaging Exclusion Criteria: * previous ovarian surgery * ovarian drilling * polycystic ovarian syndrome (PCOs).

What they're measuring

Correlation of serum anti-Müllerian hormone (AMH) level with mullerian anomalies

Timeframe: 2 years

Trial details

NCT IDNCT02436538

SponsorAhmed M.Kamel

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-11

View on ClinicalTrials.gov More Infertility trials